HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John R. Benfield Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benfield, J. R. Articles by Teplitz, R. L. Search for Related Content PubMed PubMed Citation Articles by Benfield, J. R. Articles by Teplitz, R. L.

Ann Thorac Surg 1981;32:592-601
© 1981 The Society of Thoracic Surgeons

---

Articles

A Clinically Relevant Canine Lung Cancer Model

From the Divisions of Surgery, Pathology, and Cytogenetics, City of Hope Medical Center, Duarte; and the Departments of Surgery and Pathology, UCLA School of Medicine, Los Angeles, CA

^* Address reprint requests to Dr. Benfield, Division of Surgery, City of Hope Medical Center, Duarte, CA 91010

Research on early human lung cancer is difficult; we have sought a canine correlate. Regimens included endobronchial submucosal injections and topical focal applications of benzo-[a]pyrene, nitrosomethylurea, dimethylbenzanthra-cene, and methylcholanthrene, singly or in combinations. Sustained-release discs were placed into lung parenchyma or sutured into major bronchi. Tracheal segments were isolated as cervical pedicle grafts. Gross and histological evolution was reproducible. Columnar and basal hyperplasia and squamous metaplasia were early changes. Atypia occurred within 6 weeks and was found in all dogs within 16 to 18 weeks. Invasive cancers occurred within 8 to 65 months. No tracheal graft developed cancer. Of 15 dogs with parenchymal sustained-release implants, 1 to date has developed cancer in 8 months. Four endobronchial regimens have produced 16 cancers in 56 lungs at risk for 18 to 65 months. No cancers developed in 23 lungs at risk from eight other regimens. Of 10 dogs at risk for unilateral endobronchial cancer, 5 have had cancer. Of 23 dogs with both lungs at risk, 9 developed cancer. We have shown focal carcinogenesis with well-defined pathogenesis and an extended preneoplastic period at predictable sites in a lung cancer model.

This article has been cited by other articles:

				J. R. Benfield, W. G. Hammond, E. C. Shors, R. Paladugu, H. Y. Pak, and R. L. Teplitz A Family of Epidermoid Lung Cancer Models Ann. Thorac. Surg., December 1, 1984; 38(6): 627 - 632. [Abstract] [PDF]

				R. R. Paladugu, W. G. Hammond, J. R. Benfield, T. Jensen, H. Pak, and K. Matsumura Carcinogenesis in Canine Bistomal Heterotopic Tracheal Grafts Ann. Thorac. Surg., February 1, 1984; 37(2): 111 - 114. [Abstract] [PDF]

				R. L. Teplitz, H. Y. Pak, J. R. Benfield, V. Ashdjian, S. B. Yokota, A. Heyworth, L. De Caro, and R. Paladugu Quantitative DNA: Comparative Studies of a Cellular Marker for Bronchogenic Carcinoma JAMA, February 25, 1983; 249(8): 1046 - 1049. [Abstract] [PDF]